River & Mercantile Asset Management LLP Acquires 16,529 Shares of Mylan NV (MYL)

River & Mercantile Asset Management LLP boosted its holdings in shares of Mylan NV (NASDAQ:MYL) by 25.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 81,171 shares of the company’s stock after buying an additional 16,529 shares during the quarter. River & Mercantile Asset Management LLP’s holdings in Mylan were worth $2,971,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in MYL. Stratos Wealth Partners LTD. bought a new stake in Mylan during the third quarter valued at approximately $183,000. FTB Advisors Inc. bought a new position in shares of Mylan in the second quarter worth approximately $188,000. Reilly Financial Advisors LLC boosted its position in shares of Mylan by 69.4% in the third quarter. Reilly Financial Advisors LLC now owns 5,217 shares of the company’s stock worth $191,000 after purchasing an additional 2,137 shares during the period. BB&T Corp bought a new position in shares of Mylan in the third quarter worth approximately $202,000. Finally, Sustainable Insight Capital Management LLC bought a new position in shares of Mylan in the third quarter worth approximately $226,000. Institutional investors own 82.17% of the company’s stock.

Shares of NASDAQ:MYL opened at $30.55 on Friday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.26 and a quick ratio of 0.77. Mylan NV has a fifty-two week low of $30.33 and a fifty-two week high of $47.82. The firm has a market cap of $16.42 billion, a P/E ratio of 6.70, a P/E/G ratio of 1.05 and a beta of 1.49.

Mylan (NASDAQ:MYL) last issued its earnings results on Monday, November 5th. The company reported $1.25 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.19 by $0.06. Mylan had a net margin of 4.71% and a return on equity of 19.39%. The firm had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.91 billion. During the same quarter in the prior year, the business earned $1.10 earnings per share. Mylan’s revenue for the quarter was down 4.2% on a year-over-year basis. Research analysts anticipate that Mylan NV will post 4.66 earnings per share for the current year.

A number of equities analysts have weighed in on MYL shares. Cantor Fitzgerald reiterated a “hold” rating and issued a $41.00 price target on shares of Mylan in a research report on Monday, November 5th. ValuEngine upgraded shares of Mylan from a “sell” rating to a “hold” rating in a research report on Tuesday, August 14th. Royal Bank of Canada upgraded shares of Mylan from a “sector perform” rating to an “outperform” rating and set a $53.00 price target for the company in a research report on Monday, August 13th. Morgan Stanley lowered shares of Mylan from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $46.00 to $36.00 in a research report on Tuesday, October 9th. Finally, Mizuho lowered shares of Mylan from a “buy” rating to a “neutral” rating in a research report on Friday, October 5th. Two analysts have rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $46.56.

ILLEGAL ACTIVITY WARNING: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.com-unik.info/2018/12/08/river-mercantile-asset-management-llp-acquires-16529-shares-of-mylan-nv-myl.html.

Mylan Profile

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Featured Story: Trading Penny Stocks

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan NV (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit